首页 > 最新文献

Turkish Journal of Internal Medicine最新文献

英文 中文
Comparison of the expression of GATA-3 protein from the transcription factor family and pathological prognostic parameters in invasive ductal carcinomas of the breast 乳腺浸润性导管癌中转录因子家族GATA-3蛋白表达与病理预后指标的比较
Pub Date : 2022-04-26 DOI: 10.46310/tjim.1090713
Leymune Parlak, O. Kandemir
Background GATA binding protein 3 (GATA-3) is one of the six transcription factor family members and is important for glandular development in the breast. Its expression becomes important in breast cancer. We aimed to compare GATA-3 immunoreactivity and pathological prognostic factors in patients with invasive ductal carcinoma. Material and Methods Our study was conducted retrospectively with 300 breast invasive ductal carcinoma patients who were operated on in our hospital between May 2013 and June 2014. Patient reports, slides and blocks in the pathology archive were scanned. GATA-3 immunohistochemical (IHC) staining was evaluated according to the nuclear staining, intensity and percentage. The relationship between clinicopathological prognostic parameters and GATA-3 IHC staining results was investigated. Results A positive staining was observed in 286 (95.3%) cases. According to the GATA-3 staining intensity and percentage, 210 (70%) cases stained strongly and 246 (82%) stained +4, respectively. There was a significant relationship between GATA-3 immunoreactivity with ER, PR, Cerb-B2, Ki-67, mitotic degree, mitotic count and histological grade. Conclusions There was a correlation between the high expression of GATA-3 and good prognostic markers. Hormone receptors can be evaluated with Cerb-B2 and Ki-67 and used as prognosis determinants in breast cancers. They can be used to identify both primary and secondary breast tumors.
GATA结合蛋白3 (GATA-3)是6个转录因子家族成员之一,在乳腺腺体发育中起重要作用。它的表达在乳腺癌中变得很重要。我们的目的是比较侵袭性导管癌患者的GATA-3免疫反应性和病理预后因素。材料与方法对2013年5月至2014年6月在我院行乳腺浸润性导管癌手术的300例患者进行回顾性研究。扫描病理档案中的患者报告、载玻片和切片。采用GATA-3免疫组化(IHC)染色,根据核染色、强度、百分比进行评价。探讨临床病理预后参数与GATA-3免疫组化染色结果的关系。结果阳性染色286例(95.3%)。根据GATA-3染色强度和百分比,强染色210例(70%),+4染色246例(82%)。GATA-3免疫反应性与ER、PR、Cerb-B2、Ki-67、有丝分裂程度、有丝分裂计数和组织学分级有显著相关。结论GATA-3高表达与预后指标良好相关。激素受体可以用Cerb-B2和Ki-67来评估,并作为乳腺癌预后的决定因素。它们可用于识别原发性和继发性乳腺肿瘤。
{"title":"Comparison of the expression of GATA-3 protein from the transcription factor family and pathological prognostic parameters in invasive ductal carcinomas of the breast","authors":"Leymune Parlak, O. Kandemir","doi":"10.46310/tjim.1090713","DOIUrl":"https://doi.org/10.46310/tjim.1090713","url":null,"abstract":"Background GATA binding protein 3 (GATA-3) is one of the six transcription factor family members and is important for glandular development in the breast. Its expression becomes important in breast cancer. We aimed to compare GATA-3 immunoreactivity and pathological prognostic factors in patients with invasive ductal carcinoma. \u0000Material and Methods Our study was conducted retrospectively with 300 breast invasive ductal carcinoma patients who were operated on in our hospital between May 2013 and June 2014. Patient reports, slides and blocks in the pathology archive were scanned. GATA-3 immunohistochemical (IHC) staining was evaluated according to the nuclear staining, intensity and percentage. The relationship between clinicopathological prognostic parameters and GATA-3 IHC staining results was investigated. \u0000Results A positive staining was observed in 286 (95.3%) cases. According to the GATA-3 staining intensity and percentage, 210 (70%) cases stained strongly and 246 (82%) stained +4, respectively. There was a significant relationship between GATA-3 immunoreactivity with ER, PR, Cerb-B2, Ki-67, mitotic degree, mitotic count and histological grade. \u0000Conclusions There was a correlation between the high expression of GATA-3 and good prognostic markers. Hormone receptors can be evaluated with Cerb-B2 and Ki-67 and used as prognosis determinants in breast cancers. They can be used to identify both primary and secondary breast tumors.","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84654319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of relation between JAK2 gene and thrombosis in myeloproliferative neoplasms 骨髓增生性肿瘤中JAK2基因与血栓形成关系的研究
Pub Date : 2022-04-21 DOI: 10.46310/tjim.1055305
S. Kahraman, F. Demirkan
Background Thrombotic complications are the most considerable etiology causing morbidity and mortality in patients with philadelphia (Ph) negative myeloproliferative neoplasms (MPN). There are many studies evaluating the association of JAK2 mutation and risk of thrombosis in MPN with inconclusive results. We also investigated the relation between JAK2 mutation in all Ph negative MPN and thrombosis. Material and Methods Thrombotic events and demographic features of 177 patients with Ph negative MPN were evaluated retrospectively. Results JAK2 V617 F mutation was detected in 57% of patients with essential thrombocythemia (ET), %90.3 of pateints with polycythemia vera (PV), 100% of pateints with primary myelofibrosis (PMF). Thrombotic complications occured more frequently with JAK2 mutation in all MPN patients than without (p=0.014). In JAK 2 mutation positive groups, the median age, thrombosis risk scores and leucocyte values are higher, splenomegaly and arterial and/or venous thrombosis are detected more frequently (p
背景:血栓性并发症是导致费城(Ph)阴性骨髓增生性肿瘤(MPN)患者发病率和死亡率的最重要的病因。有许多研究评估JAK2突变与MPN血栓形成风险的关系,但结果不确定。我们还研究了所有Ph阴性MPN中JAK2突变与血栓形成的关系。材料与方法回顾性分析177例Ph阴性MPN患者的血栓事件及人口学特征。结果57%的原发性血小板增多症(ET)、90.3%的真性红细胞增多症(PV)和100%的原发性骨髓纤维化(PMF)患者检测到JAK2 v617f突变。在所有MPN患者中,JAK2突变患者的血栓并发症发生率高于未突变患者(p=0.014)。在JAK 2突变阳性组中,中位年龄、血栓形成风险评分和白细胞值更高,脾肿大和动脉和/或静脉血栓形成的检测频率更高(p
{"title":"Assessment of relation between JAK2 gene and thrombosis in myeloproliferative neoplasms","authors":"S. Kahraman, F. Demirkan","doi":"10.46310/tjim.1055305","DOIUrl":"https://doi.org/10.46310/tjim.1055305","url":null,"abstract":"Background Thrombotic complications are the most considerable etiology causing morbidity and mortality in patients with philadelphia (Ph) negative myeloproliferative neoplasms (MPN). There are many studies evaluating the association of JAK2 mutation and risk of thrombosis in MPN with inconclusive results. We also investigated the relation between JAK2 mutation in all Ph negative MPN and thrombosis. \u0000Material and Methods Thrombotic events and demographic features of 177 patients with Ph negative MPN were evaluated retrospectively. \u0000Results JAK2 V617 F mutation was detected in 57% of patients with essential thrombocythemia (ET), %90.3 of pateints with polycythemia vera (PV), 100% of pateints with primary myelofibrosis (PMF). Thrombotic complications occured more frequently with JAK2 mutation in all MPN patients than without (p=0.014). In JAK 2 mutation positive groups, the median age, thrombosis risk scores and leucocyte values are higher, splenomegaly and arterial and/or venous thrombosis are detected more frequently (p","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"63 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82076429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV-Associated Opportunistic Pneumonia Case Mimicking Covid-19 Pneumonia 模拟Covid-19肺炎的hiv相关机会性肺炎病例
Pub Date : 2022-03-17 DOI: 10.46310/tjim.926630
Sedat Celikci, E. Yılmaz
Cytomegalovirus (CMV) pneumonia is a rare opportunistic infection in the progression of human immunodeficiency virus (HIV) infection. Also, COVID-19 has been named a pandemic since the beginning of 2020. During this period, physicians were exposed to many COVID-19 cases, and it was challenged to consider different diagnoses in patients who applied to the emergency room with lung complaints and bilateral pneumonia. Here we reported a 30-year-old man diagnosed with HIV- associated opportunistic CMV pneumonia mimicking COVID-19. The diagnosis of CMV pneumonia was obtained through consistent clinical, radiological, microbiological and cytologic examinations. The patient made a complete clinical recovery after being initialized on anti-CMV treatment.
巨细胞病毒(CMV)肺炎是人类免疫缺陷病毒(HIV)感染进展过程中罕见的机会性感染。此外,自2020年初以来,COVID-19已被命名为大流行。在此期间,医生接触了许多COVID-19病例,对肺部主诉和双侧肺炎申请急诊室的患者进行不同诊断提出了挑战。在这里,我们报告了一名30岁的男性被诊断为HIV相关的机会性巨细胞病毒肺炎,模仿COVID-19。通过一致的临床、放射学、微生物学和细胞学检查获得巨细胞病毒肺炎的诊断。患者经抗巨细胞病毒初始化治疗后临床完全康复。
{"title":"HIV-Associated Opportunistic Pneumonia Case Mimicking Covid-19 Pneumonia","authors":"Sedat Celikci, E. Yılmaz","doi":"10.46310/tjim.926630","DOIUrl":"https://doi.org/10.46310/tjim.926630","url":null,"abstract":"Cytomegalovirus (CMV) pneumonia is a rare opportunistic infection in the progression of human immunodeficiency virus (HIV) infection. Also, COVID-19 has been named a pandemic since the beginning of 2020. During this period, physicians were exposed to many COVID-19 cases, and it was challenged to consider different diagnoses in patients who applied to the emergency room with lung complaints and bilateral pneumonia. Here we reported a 30-year-old man diagnosed with HIV- associated opportunistic CMV pneumonia mimicking COVID-19. The diagnosis of CMV pneumonia was obtained through consistent clinical, radiological, microbiological and cytologic examinations. The patient made a complete clinical recovery after being initialized on anti-CMV treatment.","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"225 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77451587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Single Center Retrospective Analysis of Patients with Recurrent Papillary Thyroid Carcinoma Undergoing Radiofrequency Ablation 射频消融治疗复发性甲状腺乳头状癌患者的单中心回顾性分析
Pub Date : 2022-03-09 DOI: 10.46310/tjim.1073526
Erhan Hocaoğlu, E. Aydemir, C. Ateş, Filiz MERCAN SARIDAŞ, O. F. Nas, M. F. Inecikli, S. Cander, Özen Öz Gül, E. Ertürk, C. Ersoy
Background Radiofrequency ablation (RFA) is used in selected patients with recurrent or metastatic thyroid cancer who have high surgical risk or do not accept surgical treatment. However, long-term follow-up data are limited. Here, we present our single-center experience with the use of RFA in the treatment of recurrent or metastatic papillary thyroid carcinoma (PTC). Material and Methods Patients
{"title":"A Single Center Retrospective Analysis of Patients with Recurrent Papillary Thyroid Carcinoma Undergoing Radiofrequency Ablation","authors":"Erhan Hocaoğlu, E. Aydemir, C. Ateş, Filiz MERCAN SARIDAŞ, O. F. Nas, M. F. Inecikli, S. Cander, Özen Öz Gül, E. Ertürk, C. Ersoy","doi":"10.46310/tjim.1073526","DOIUrl":"https://doi.org/10.46310/tjim.1073526","url":null,"abstract":"Background Radiofrequency ablation (RFA) is used in selected patients with recurrent or metastatic thyroid cancer who have high surgical risk or do not accept surgical treatment. However, long-term follow-up data are limited. Here, we present our single-center experience with the use of RFA in the treatment of recurrent or metastatic papillary thyroid carcinoma (PTC). Material and Methods Patients","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"62 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74070819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the relationship between dehydroepiandrosterone sulfate-total testosterone ratio and metabolic parameters in patients with polycystic ovary syndrome 多囊卵巢综合征患者脱氢表雄酮-总睾酮比值与代谢参数关系的评价
Pub Date : 2022-03-09 DOI: 10.46310/tjim.1070164
Özen Öz Gül, S. Cander
Background In this study we aimed to evaluate the correlations between dehydroepiandrosterone sulfate-total testosterone (DHEAS/TT) ratio and insulin resistance, glycemic and lipid parameters. Material and Methods A total of 35 patients with polycystic ovary syndrome (PCOS) and 34 healthy volunteers were included in the study. Anthropometric, clinical, biochemical, lipid and glycemic measurements were performed according to routine standards. Patients’ demographic, clinical, anthropometric, biochemical, glycemic, lipid and hormonal parameters were measured and recorded. DHEAS/TT ratio was calculated in all patients. DHEAS/TT ratio and metabolic parameters were compared between the PCOS and control groups. Results There were significant differences between the PCOS and control groups in terms of fasting blood glucose, total cholesterol, high density lipoprotein cholesterol (HDL-c), low density lipoprotein cholesterol (LDL-c), triglycerides, insulin and homeostatic model assessment-insulin resistance (HOMA-IR)
在本研究中,我们旨在评估脱氢表雄酮硫酸盐-总睾酮(DHEAS/TT)比率与胰岛素抵抗、血糖和血脂参数的相关性。材料与方法选取35例多囊卵巢综合征(PCOS)患者和34名健康志愿者作为研究对象。按常规标准进行人体测量、临床、生化、血脂和血糖测量。测量并记录患者的人口学、临床、人体测量、生化、血糖、血脂和激素等参数。计算所有患者的DHEAS/TT比值。比较PCOS组与对照组DHEAS/TT比值及代谢参数。结果PCOS组与对照组在空腹血糖、总胆固醇、高密度脂蛋白胆固醇(HDL-c)、低密度脂蛋白胆固醇(LDL-c)、甘油三酯、胰岛素及稳态模型评估-胰岛素抵抗(HOMA-IR)指标均有显著差异。
{"title":"Evaluation of the relationship between dehydroepiandrosterone sulfate-total testosterone ratio and metabolic parameters in patients with polycystic ovary syndrome","authors":"Özen Öz Gül, S. Cander","doi":"10.46310/tjim.1070164","DOIUrl":"https://doi.org/10.46310/tjim.1070164","url":null,"abstract":"Background In this study we aimed to evaluate the correlations between dehydroepiandrosterone sulfate-total testosterone (DHEAS/TT) ratio and insulin resistance, glycemic and lipid parameters. Material and Methods A total of 35 patients with polycystic ovary syndrome (PCOS) and 34 healthy volunteers were included in the study. Anthropometric, clinical, biochemical, lipid and glycemic measurements were performed according to routine standards. Patients’ demographic, clinical, anthropometric, biochemical, glycemic, lipid and hormonal parameters were measured and recorded. DHEAS/TT ratio was calculated in all patients. DHEAS/TT ratio and metabolic parameters were compared between the PCOS and control groups. Results There were significant differences between the PCOS and control groups in terms of fasting blood glucose, total cholesterol, high density lipoprotein cholesterol (HDL-c), low density lipoprotein cholesterol (LDL-c), triglycerides, insulin and homeostatic model assessment-insulin resistance (HOMA-IR)","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"177 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76873191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A finding that is not clear what will emerge when you see it: Hypoalbuminemia 这个发现还不清楚当你看到它的时候会发生什么:低白蛋白血症
Pub Date : 2022-03-09 DOI: 10.46310/tjim.1073366
E. Simdi, Mirac Vural Keskinler, Ender İğneci
{"title":"A finding that is not clear what will emerge when you see it: Hypoalbuminemia","authors":"E. Simdi, Mirac Vural Keskinler, Ender İğneci","doi":"10.46310/tjim.1073366","DOIUrl":"https://doi.org/10.46310/tjim.1073366","url":null,"abstract":"","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82537696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Cause of Hypokalemia: Ectopic ACTH Syndrome 低钾血症的罕见原因:异位ACTH综合征
Pub Date : 2022-03-09 DOI: 10.46310/tjim.1078178
Merve Tekinyildiz, S. Kayhan, M. Çalapkulu, R. Özkan, I. Akdag
in the presence of hypokalemia accompanying hypertension and proximal muscle weakness, if the patient also has progressive weight loss
{"title":"A Rare Cause of Hypokalemia: Ectopic ACTH Syndrome","authors":"Merve Tekinyildiz, S. Kayhan, M. Çalapkulu, R. Özkan, I. Akdag","doi":"10.46310/tjim.1078178","DOIUrl":"https://doi.org/10.46310/tjim.1078178","url":null,"abstract":"in the presence of hypokalemia accompanying hypertension and proximal muscle weakness, if the patient also has progressive weight loss","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"13 2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82592019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ground Glass Appearance During the Pandemic Period: Everolimus Induced Interstitial Pneumonia 大流行期间的磨玻璃外观:依维莫司诱导的间质性肺炎
Pub Date : 2022-03-09 DOI: 10.46310/tjim.1078775
Sidelya Ecem Yi̇ği̇t, İffet Beril Gökmen, Y. Okuturlar
to
{"title":"Ground Glass Appearance During the Pandemic Period: Everolimus Induced Interstitial Pneumonia","authors":"Sidelya Ecem Yi̇ği̇t, İffet Beril Gökmen, Y. Okuturlar","doi":"10.46310/tjim.1078775","DOIUrl":"https://doi.org/10.46310/tjim.1078775","url":null,"abstract":"to","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73078494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-COVID ANCA-Associated Vasculitis: A Case Report 冠状病毒后anca相关性血管炎1例报告
Pub Date : 2022-03-09 DOI: 10.46310/tjim.1073603
Kübra Özeri̇k, Mehmet Sezen, A. Yildiz, K. Dilek, M. Güllülü, M. Yavuz, A. Oruc, S. Güllülü, A. Ersoy
{"title":"Post-COVID ANCA-Associated Vasculitis: A Case Report","authors":"Kübra Özeri̇k, Mehmet Sezen, A. Yildiz, K. Dilek, M. Güllülü, M. Yavuz, A. Oruc, S. Güllülü, A. Ersoy","doi":"10.46310/tjim.1073603","DOIUrl":"https://doi.org/10.46310/tjim.1073603","url":null,"abstract":"","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"84 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74190225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Cause Of Anemia Etiology: Gastrointestinal Stromal Tumors 一种罕见的贫血病因:胃肠道间质瘤
Pub Date : 2022-03-09 DOI: 10.46310/tjim.1072659
H. Şen, A. Kırık, Erdoğan Bülbül, T. Doğru
{"title":"A Rare Cause Of Anemia Etiology: Gastrointestinal Stromal Tumors","authors":"H. Şen, A. Kırık, Erdoğan Bülbül, T. Doğru","doi":"10.46310/tjim.1072659","DOIUrl":"https://doi.org/10.46310/tjim.1072659","url":null,"abstract":"","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"87 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84112627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turkish Journal of Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1